Total₹1800
| Wiki Information | Bivalirudin API Manufacturers |
| Indication & Benefits | Bivalirudin is used For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned. |
| How To Use | |
| Deficiency | |
| Recommended For Better | |
| Pregnancy Warning | |
| Side Effects | |
| Disclaimer | Information provided on this site is intended for use only for a particular country. Products protected under valid patents are not manufactured, offered, or supplied by ENOMARK. The product information provided on this site is for general information purposes only and does not construe as commercial or approved product information. Consumers should not construe any information herein as medical advice or as a substitute, The Company and its affiliates accept no responsibility for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing as well as all terms and conditions of the Legal Statement. |
| Products |